Expert Guide to Selecting Medical Device Suppliers
What’s Hot and What’s Not in IO 2021?
Oncology venture funding, IPOs and partnerships have been exceptionally high in deal volume and values. Cancer continues to be the leading therapeutic area in the number and size of early deals, and the oncology pipeline continues to be a rich source of both follow-on agents as well as first-in-class programs.
Paradigm Changing Technologies in Oncology
Pivot to Cash: Bankruptcy & Restructuring in a Distressed Environment
Microbiome: Hope or Hype?
How to Apply the Golden Rule of Research to your Trial Master File
This webinar evaluated the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.
Biotech and Pharma Licensing Negotiations
The Nuts & Bolts of Selecting a Contract Research Organization
This webinar evaluated how to determine internal champions/selection committees, strategic sourcing/procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.
Getting Ready for a Biopharma Partnering Deal
What's Hot and What's Not in Oncology Licensing in 2020?
Adoptive Cell Therapy in Solid Tumors
Predictable Failure (And How to Avoid It) for Early-Stage Life Science Companies
In this webinar, Dr. Lucia Mokres breaks down the six major stakeholder categories relevant to most life science companies, and shares key strategies for closing the knowledge gap between founders and their market success.